Testing Methods to Discover EGFR Exon-20 Disease - Lung Cancer Video Library

Testing Methods to Discover EGFR Exon-20 Disease - Lung Cancer Video Library

Emerging Treatments and Clinical Trials for EGFR Exon-20 - Lung Cancer Video LibraryПодробнее

Emerging Treatments and Clinical Trials for EGFR Exon-20 - Lung Cancer Video Library

Amivantamab and Mobocertinib for EGFR Exon-20 Disease - Lung Cancer Video LibraryПодробнее

Amivantamab and Mobocertinib for EGFR Exon-20 Disease - Lung Cancer Video Library

Lung Cancer Video Library 2020 - PATEL Emerging Molecular Targets in NSCLC EGFR Exon 20Подробнее

Lung Cancer Video Library 2020 - PATEL Emerging Molecular Targets in NSCLC EGFR Exon 20

Sunvozertinib & EGFR Exon 20 Insertion NSCLC-Leading Developments & Current Questions in Lung CancerПодробнее

Sunvozertinib & EGFR Exon 20 Insertion NSCLC-Leading Developments & Current Questions in Lung Cancer

EGFR Exon 20 Mutations in Non–Small Cell Lung CancerПодробнее

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLCПодробнее

Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLC

Selpercatinib and Pralsetinib in RET + Disease - Lung Cancer Video LibraryПодробнее

Selpercatinib and Pralsetinib in RET + Disease - Lung Cancer Video Library

EGFR Exon-20 Mutation - Lung Cancer Video LibraryПодробнее

EGFR Exon-20 Mutation - Lung Cancer Video Library

Finding Clinical Trials for RET+ Disease - Lung Cancer Video LibraryПодробнее

Finding Clinical Trials for RET+ Disease - Lung Cancer Video Library

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 InsertionПодробнее

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

Amivantamab and Mobocertinib: Side Effects and Treatment Timing - Lung CancerПодробнее

Amivantamab and Mobocertinib: Side Effects and Treatment Timing - Lung Cancer

Treatments for patients with NSCLC carrying EGFR exon 20 insertionsПодробнее

Treatments for patients with NSCLC carrying EGFR exon 20 insertions

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertionsПодробнее

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions

Latest in EGFR-positive NSCLC with exon 20 insertion mutationsПодробнее

Latest in EGFR-positive NSCLC with exon 20 insertion mutations

What is an EGFR mutation in lung cancer?Подробнее

What is an EGFR mutation in lung cancer?

ASCO 2021 Lung Recap: Amivantamab and Mobocertinib for EGFR Exon 20Подробнее

ASCO 2021 Lung Recap: Amivantamab and Mobocertinib for EGFR Exon 20

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLCПодробнее

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC

Tackling EGFR Exon 20 Mutations: Clinical Challenges, New Insights Part 1Подробнее

Tackling EGFR Exon 20 Mutations: Clinical Challenges, New Insights Part 1